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1. Introduction 
Estrogens and other steroid hormones initiate 
their action by first binding to a specific ytoplasmic 
protein, the receptor; the resulting complex is then 
translocated to the nucleus where the hormone 
receptor complex binds to specific acceptor sites on 
the chromatin. It is assumed that the cytoplasmic 
receptor and the nuclear eceptor are one and the 
same protein or possess at least a precursor-product 
relationship although no clear-cut demonstration 
exists as yet. Thus, disappearance of cytoplasmic 
estrogen receptor in rat uterus [1-3] was followed 
by appearance ofnuclear eceptor within 30 min after 
hormone injection [3,4]. Similar data have been 
published for chick oviduct [5,6]. Cytosol as well as 
nuclei from rat liver contain estradiol binding proteins 
[7], so does chick liver chromatin [8] and supposedly 
also chick liver cytosol [9] although the latter data 
could not be confirmed [8,10,11] nor have we ever 
found receptor activity in chick liver cytoplasm. 
Nevertheless, to get information on a possible very 
rapid translocation i  this particular target issue of 
a cytoplasmic receptor molecule to the nucleus, we 
approached the problem as follows. Using an intrave- 
nous injection route leading directly to the liver - 
described in this paper - we were able to immediately 
bring estradiol in contact with the target organ and 
thus to determine as a function of time the appear- 
ance of nuclear estradiol receptor. Indeed, within one 
minute we could already show half maximal nuclear 
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receptor activity; full activity being attained within 
10 min. In spite of lack of evidence for a cytoplasmic 
receptor, this does not exclude an extremely rapid 
translocation. Further, we show here that cyclo- 
heximide given in vivo partly prevents this appearance 
of receptor activity which suggests either de novo 
synthesis of the receptor molecule, or its subunits, or 
the possible involvement of a polypeptide necessary 
for the association of the nuclear eceptor with the 
acceptor sites on the chromatin. 
Lastly, following a single injection of estradiol, we 
studied the estrogen receptor in chick liver nuclei over 
a period of several days and found that it disappeared 
so slowly that after a week levels were still greater 
than those of the controls. This may be why a second 
injection of estradiol given at this time produces 
vitellogenin faster and in larger amounts [ 12,13]. 
The facts that estradiol receptor can be shown to 
appear already within minutes in chick liver nuclei 
after in vivo estrogen treatment and that increases in 
nuclear RNA [14], synthesis of specific nuclear non- 
histone proteins [15] and activities of DNA dependent 
RNA polymerases occur within hours [ 16,17] support 
the idea that the appearance ofestrogen receptor may 
be the key event upon which depend all further bio- 
chemical steps leading to the synthesis of vitellogenin. 
2. Experimental 
2.1. Animals 
One week old white leghorn chicks of both sexes 
were obtained locally and maintained in electrically 
heated brooders. Chicks of either sex were used when 
they had reached aminimum body weight of 100 g, 
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after an overnight fast. They were injected with the 
hormone by two different,routes: (a)intravenously: 
17~-estradiol was dissolved in the quantities stated in 
an emulsion of sesame oil with phosphate buffered 
saline (Dulbecco's PBS). The emulsion was prepared 
according to Schurr [18] with a modification: a 
mixture consisting of 2.2 ml of sesame oil and 0.3 g 
of egg lecithin was homogenized at60°C under a 
stream of nitrogen in a teflonglass homogenizer with 
7.5 ml of a solution containing 0.3% of pluronic F-68 
in PBS. Control animals received emulsion only. Birds 
were anaesthetized with nembutal (1.2 ml/kg) and the 
vena pancreatica duodenalis exposed surgically. 
Injections were done into this vein which leads 
directly into the portal vein. Sham operations with 
nembutal only did not affect he estradiol receptor 
level in any way. (b) Subcutaneously: 17fl-estradiol 
(20 mg/kg body weight) was dissolved in 0.1 ml 
propylene glycol and injected under the skin of the 
leg. Control animals received propylene glycol only. 
In preliminary studies, optimum conditions 
regarding injected 17/~-estradiol concentration, weight 
of animals, etc., as a function of nuclear eceptor 
activity were established. These demonstrated that 
birds up to 200 g body weight gave maximum 
receptor activities of approximately 150 fmol/mg 
protein when injected subcutaneously with a minimum 
of 10 mg estradiol/kg body weight. Routinely, birds 
weighing up to 200 g were used and injected with 
20 mg estradiol/kg body weight. 
2.2. Preparation of nuclei and high salt extraction of 
estradiol receptor 
Birds were killed and the livers immediately cooled 
by perfusion of ice-cold PBS through the vena cava 
caudalis. Livers were then homogenized in three 
volumes of buffer A (0.32 M sucrose, 2 mM KH2PO4, 
pH 5.8, 3 mM MgC12,0.5 mM mercaptoethanol) with 
7 strokes in a Teflon-glass homogenizer at2000 rev/ 
rain. The homogenate was layered over an equal 
volume of the above buffer made in 0.6 M sucrose 
and centrifuged at 400g for 10 min. The purified 
nuclei were resuspended in buffer E (0.5 M KC1, 10 
mM Tris, pH 8.0, 1 mM EDTA, 5 mM CaC12), frozen, 
thawed and centrifuged at 100 O00g for 45 min. This 
supernatant fluid contained thehigh-salt extractable 
hormone receptor complex which was further purified 
through an ammonium sulfate precipitation step. For 
this the supernatant fluid was adjusted to a final 
concentration f 3-5 mg protein/ml with buffer E 
and a saturated solution of ammonium sulfate in 
100 mM Tris, pH 8.0, was added under a stream of 
nitrogen to 42% saturation. The resulting precipitate 
was centrifuged at 20 000 g for 10 min and the pellet 
was dissolved in buffer E followed by a second cen- 
trifugation at 20 000 g for 30 min. This supernatant 
fraction was quantitatively assayed for receptor 
activity as follows. 
2.3. Determination festradiol receptor 
The method of Mester and Baulieu [ 11 ] was used 
with some modifications: To 3 ml of supernatant 
fluid obtained after the ammonium sulfate step, 
containing up to 4 mg protein/ml, we added 0.7 ml of 
buffer E containing in addition 0.5% charcoal and 
0.005% dextran T 70 (buffer F) and incubated this 
mixture for 30 min at 37°C. The charcoal was removed 
by centrifugation. This preincubation procedure 
quantitatively removes the endogenous e tradiol [11 ]. 
For the binding assay, aliquots of 300/al of the 
charcoal-treated extract were incubated,at 2°C for 
2 h with varying concentrations of [aH]estradiol in
the range of 10-8-10 -l° M in a total volume of O.5 
ml buffer E. The reaction was terminated by the 
addition of 100 tzl buffer F and further incubation 
at 2°C for 30 min followed by removal of the charcoal 
by centrifugation. A 0.5 ml portion of the supernatant 
fluid (bound radioactivity) and also of the [aH]estra- 
diol (total radioactivity) were counted in a scintilla- 
tion cocktail consisting of 1% butyl PBD in a mixture 
of Triton X-IO0 and xylene (3 : 7) using an Isocap 
liquid scintillation counter. The results obtained were 
plotted according to Scatchard (19). A typical .plot. 
is shown in fig. 1. 
2.4. Chemicals 
Butyl-PBD and 17/~-estradiol were both obtained from 
CIBA-GEIGY Limited, Basel; pluronic F-68 was 
from Wyandotte Chemical Corp., Wyandotte, 
Michigan, USA; charcoal (norite A) was bought from 
Serva Ltd., Heidelberg, Germany, and dextran T 70 
from Pharmacia, Uppsala, Sweden. Cycloheximide 
was from Calbiochem. New England Nuclear was the 
supplier for [6,7 -3 H(N)] estradiol- 17/3 (spec.act. 48 Ci/ 
mmol). All other chemicals were of analytical grade. 
294 
Volume 66, number 2 FEBS LETTERS July 1976 
0.1 
10 -~o 
BIu 
O.5 
A 
A 
2.10"1°M BOUND 
Fig.1. Scatchard analysis of the binding of [3H]estradiol by 
high-affinity sites on the receptor. Experimental details are 
described in the text. Bound estradiol (B) was determined 
directly as dpm and unbound estradiol (U) was calculated 
from the total of estradiol added. No unlabelled estradiol 
added: (~x___zx). From the slope the calculated issociation 
constant, K D = 4.4 × 101° M and from the intercept on the 
abscissa, the concentration f binding sites = 2.1 X 10 -t° M 
are obtained. If a 100-fold excess of unlabelled estradiol is 
present during the incubation, a horizontal line is obtained 
(o - -o ) .  
3. Results 
3.1. Rapid appearance of receptor after intravenous 
injection 
The appearance of the estrogen receptor after 
injecting estradiol directly into the portal vein was 
extremely rapid. In less than 1 min, the receptor 
concentration had risen to four times the base level 
(fig.2) and within 10 min it had reached its maximum. 
This could be achieved with as little as 2 pg estradiol/. 
kg only if the injection site was the portal vein. Wing 
vein injections required at least 10 times as much 
estradiol to obtain maximum receptor levels because 
of the dilution of the hormone when it circulates 
throughout the body before reaching the liver. The 
delay in appearance, however, was negligible (actual 
data not shown). Injections of physiological quantities 
of estradiol of the order of 50 pg/ml [20] did not 
result in measurable increases of nuclear estrogen 
receptor. 
3.2. Effect of inhibition of protein synthesis on the 
appearance of the receptor 
In a preliminary test we established the efficiency 
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Fig.2. Kinetics of appearance of nuclear estrogen receptor 
after portal vein injection of estradiol. Groups of anaesthetized 
chicks (130 +- 20 g body weight) were injected with estradiol 
(50/~g/kg) into the portal vein. Chicks were sacrificed at 
various times after injection as indicated in the graph and the 
hormone receptor was assayed as described in the experimental 
section. 
of cycloheximide to inhibit protein synthesis. Chicks 
received 1 mg cycloheximide/kg into the wing vein 
and 5 mg/kg intraperitoneally immediately thereafter. 
This led to > 95% inhibition of [3H]leucine incorpo- 
ration into liver proteins for the period 5 -120  min 
after injection (table 1). Groups of three chicks were 
given 5 min pulses of 50/ag estradiol/kg into the 
wing vein at various times after injection of cyclo- 
hexirnide as above (fig.3). We observed an almost 
Table 1 
Inhibition of protein synthesis n chick liver after 
in vivo cycloheximide treatment 
Time after cyclo- [14C] Amino acid incorporation 
heximide (min) (dpm/mg protein) 
0 3360 +- 400 
5 115 +- 20 
120 50 -+ 10 
Groups of 3 chicks (130 +- 10 g) were injected with 1 mg/kg 
cycloheximide into the wing vein at time 0, followed by 
5 mg/kg cycloheximide intraperitoneaUy. 10 min before the 
indicated times, a 10 rain pulse of 200 t~l [14C]amino acid 
mixture (50 t~Ci/ml, Radiochemical Centre, Amersham) was 
given into the wing vein. Controls received the amino acid 
pulse only. Chicks were sacrificed, their liver excised and the 
amino acid incorporation i to total proteins determined 
according to Jost et al. [16]. 
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Fig.3. Effect of inhibition of protein synthesis on the 
appearance of the nuclear eceptor. Chicks (130 ~ 20 g body 
weight) were injected with 1 mg cycloheximide/kg into the 
wing vein followed by 5 mg/kg cycloheximide intraperitone- 
ally. The estrogen receptor was induced by a 5 rain pulse of 
estradiol (50 ~ag/kg) iven into the wing vein at varying times 
after cycloheximide treatment (empty bars). Control chicks 
received no treatment (horizonally lined bars), cycloheximide 
only (vertically lined bars), or estradiol only dotted bars. 
normal appearance of hormone receptor with an 
estradiol pulse beginning 10 min after cycloheximide 
administration, the response then gradually diminished 
when estradiol was given 30 min, 60 min and 90 min 
after cycloheximide. Surprisingly, the receptor res- 
ponse never disappeared completely and receptor 
levels of twice the controls value remained, even 2 h 
after cycloheximide treatment. 
3.3. Long-term kinetics of nuclear estrogen-receptor 
concentration as a function of estradiol 
For these studies estradiol was injected subcutane- 
ously. Fig.4A shows the initial rapid increase of 
nuclear eceptor and its slow disappearance over days 
concomitantly with the disappearance of the hormone 
from the blood (fig.4B). This figure also shows that at 
the site of injection a depot of estradiol is formed 
which diminishes very rapidly during the first 24 h, 
then much more slowly and steadily for more than a 
week. The rate of appearance of the nuclear eceptor, 
measured in crude extracts, was biphasic: there was a 
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Fig.4. Long-term kinetics of estrogen receptor as a function of estradiol concentration. 4 mg [3H]estradiol (2 × 10 ~ dpm/mg) 
dissolved in propylene glycol was injected subcutaneously into chicks (200 -+ 20 g body weight). Chicks were sacrificed at the 
times indicated and [3H]estradiol was counted after combustion i  an oxidizer (model Oximat, Intertechnique) in portions of 
skin taken from the injection site (e  a), in portions of liver (~ 4) and of blood (t~--D). In parallel, an equal group of 
chicks received 20 mg/kg estradiol subcutaneously. From these birds nuclear extracts were prepared at the times indicated and 
the estrogen receptor assayed as described, 
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very fast increase within the first hour to a level of  
70-100 fmol/mg protein followed by a slower 
increase within the next 6 -20  h to a peak level of  
140 fmol/mg protein. 
4. Discussion 
Our present data show 3 facts: (a) estrogen receptor 
appearance in chick liver nuclei in a matter of 
minutes, (b) inhibition of protein synthesis in part 
inhibits appearance of estrogen receptor and (c) our 
long-term data show that estrogen receptor activity 
still persists after 7 days, a time at which vitellogenfn 
synthesis has ceased [12]. The last finding may be 
of prime importance because it is known that a 
secondary stimulation of chicks by estradiol results 
in a much faster and greater production of vitello- 
genin [12,13]. 
A level of approximately 1000 high-affinity estra- 
diol binding sites/cell (g  D = 10 -9 -10  -1° M) has been 
determined from studies of liver chromatin from 
roosters pretreated with 17/~-estradiol for periods of 
15 min to 24 h [21]. Our results confirm these data 
of Gschwendt [8,21] and extend the study in the 
sense that we were able to determine receptor activity 
as soon as 1 min after hormone treatment. One can 
calculate that in our control animals there were 
approximately 140 sites/cell in good agreement with 
the data of Lebeau et al. [22] who found 100 such 
sites/cell in liver nuclei from untreated animals; this 
number was increased 3 -5  times in laying hens or 
24 h estrogen-treated chicks. These figures were 
arrived at by combining a high-salt extraction method 
with a trypsin method while we used only a high-salt 
method but in combination with freezing and thawing. 
Gschwendt [8] also demonstrated that the estradiol 
binding capacity of rooster liver chromatin prepared 
from animals which had received cycloheximide was 
decreased by 60% within 30 min. We have confirmed 
this and we should like to suggest hat a rapidly 
turning over polypeptide is most probably a crucial 
factor in the estrogen binding property of the receptor 
molecule. This could be one of the subunits of the 
receptor itself [23] or a polypeptide involved in 
binding the hormone receptor complex to the acceptor 
site. That chromosomal proteins are involved was 
shown by Gschwendt [21] who was unable to find a 
binding capacity after pronase treatment of chromatin. 
Estrogen receptor binding to its acceptor site may 
well be the event that triggers off subsequent bio- 
chemical sequences. We have recently shown by 
reconstitution experiments [24] that estrogen receptor 
complex activates RNA polymerases I and II in chick 
liver chromatin. Such an activation - of the nucleolar 
RNA polymerase I in calf uterus - had already been 
proposed by Arbaud et al. in 1971 [25,26] and an 
association of RNA polymerase I with estrogen recep- 
tor in quail oviduct evident during purification was 
demonstrated by Miiller et al. [27]. In conclusion, 
the increased number of high affinity binding sites for 
estradiol found in target cells occurring extremely 
rapidly after in vivo hormone treatment and dis- 
appearing extremely slowly may well be the prerequi- 
Site biochemical event which precedes changes in 
genetic transcriptional ctivity. 
References 
[1] Toft, D. and Gorski, J. (1966) Proc. Natl. Acad. Sci. US 
55, 1574-1581. 
[21 Jensen, E. V. and DeSombre, E. R. (1973) Science 182, 
126-134. 
[31 O'Malley, B. W. and Means, A. R. (1974) Science 183, 
610-620. 
[4] Mester, J. and Baulieu, E. E. (1975) Biochem. J. 146, 
617-623. 
[51 Cox, R. F., Catlin, G. H. and Carey, N. H. (1971) Eur. J. 
Biochem. 22, 46-56. 
[61 Kalimi, M., Tsai, S. Y., Tsai, M.-J., Clark, J. H. and 
O'Malley, B. W. (1976) J. Biol. Chem. 251,516-523. 
[7] Eisenfeld, A. J., Aten, R., Weinberger, M., Haselbacher, G., 
Halpern, K. and Krakoff, L. (1976) Science 191, 
862-865. 
[8] Gschwendt, M. and Kittstein, W. (1974) Biochim. 
Biophys. Acta 361, 84-96. 
[9] Arias, F. and Warren, J. C. (1971) Biochim. Biophys. 
Acta 230, 550-559. 
[10] Ozon, R. and Bell6, R. (1973) Biochim. Biophys. Acta 
297, 155-163. 
[11] Mester, J. and Baulieu, E. E. (1972) Biochim. Biophys. 
Acta 261,236-244. 
[121 J ost, J.-P., Keller, R. and Dierks-Ventling, C. (1973) 
J. Biol. Chem. 248, 5262-5266. 
[13] Deeley, R. G.~ Mullinix, K. P., Wetekam, W., 
Kronenberg, H. M., Mayers, M., Eldridge, J. D. and 
Goldberger, R. F. (1975) J. Biol. Chem. 250, 9060--9066. 
[14] Dierks-Ventling, C. and Jost, J.-P. (1974) J. Cell Biol. 
63, 84a. 
297 
Volume 66, number 2 FEBS LETTERS July 1976 
[15] Dierks-Ventling, C. and Jost, J.-P. (1974) Eur. J. 
Biochem. 50, 33-40. 
[16] Bieri, F. and Dierks-Ventling, C. (1975) Experientia 31, 
734. 
[17] Van den Berg, J. A., Kooistra, T., Ab, G. and Gruber, M. 
(1974) Biochem. Biophys. Res. Comm. 61,367-374. 
[18] Schurr, P. E. (1969) Cancer Res. 29, 258-260. 
[19] Scatchard, G. (1949) Ann. N.Y. Acad. Sci. 51,660-672. 
[20] Schr6cknadel, H., Bator, A. and Frick, J. (1973) 
Steroids 22, 767-773. 
[21] Geschwendt, M.and Kittstein, W. (1973) Hoppe-Seyler's 
Z. Physiol. Chem. 354, 1642-1644. 
[22] Lebeau, M. C., Massol, N. and Baulieu, E. E. (1974) 
FEBS Lett. 43, 107-111. 
[23] O'Malley, B. W. (1976) ICN-UCLA Symposium on 
Molecular Mechanisms in the Control of Gene Expression, 
in press. 
[24] Dierks-Ventling, C. and Bieri-Bonniot, F. (1976) 
ICN-UCLA Symposium on Molecular Mechanisms in the 
Control of Gene Expression, inpress. 
[25] Arnaud, M., Beziat, Y., Guilleux; J. C., Hough, A., 
Hough, D. and Mousseron-Canet, M. (1971) Biochim. 
Biophys. Acta 232, 117-131. 
[26] Arnaud, M., Beziat, Y., Borgna, J. L., GuiUeux, J. C. 
and Mousseron-Canet, M. (1971) Biochim. Biophys. 
Acta 254, 241-254. 
[27] Mfiller, W. E. G., Totsuka, A. and Zahn, R. K. (1974) 
Biochim. Biophys. Acta 366, 224-233. 
298 
